TY  - JOUR
AU  - Immisch, Lena
AU  - Papafotiou, George
AU  - Popp, Oliver
AU  - Mertins, Philipp
AU  - Blankenstein, Thomas
AU  - Willimsky, Gerald
TI  - Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al.
JO  - Journal for ImmunoTherapy of Cancer
VL  - 11
IS  - 3
SN  - 2051-1426
CY  - London
PB  - BioMed Central
M1  - DKFZ-2023-00531
SP  - e006784
PY  - 2023
KW  - Antigens, Neoplasm (Other)
KW  - Immunotherapy (Other)
KW  - Immunotherapy, Adoptive (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:36918223
DO  - DOI:10.1136/jitc-2023-006784
UR  - https://inrepo02.dkfz.de/record/274311
ER  -